Circulating biomarkers offer quantitative measures to assess key processes involved in MI, including cardiomyocites injury (high‐sensitivity troponin T), inflammation (high‐sensitivity CRP, IL‐6), and endothelial dysfunction (ADMA) [12]. The gene discussed is CRP; the disease is myocardial infarction.